Dr. David Eric Piccioni, MD, PhD

Dr. Piccioni practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Piccioni's NPI, 1851542575, was assigned on October 1, 2008. Dr. Piccioni graduated from Jacobs School of Medicine and Biomedical Sciences in 2005. Dr. Piccioni's California license number on file is A100663.

Dr. Piccioni's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Piccioni's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Piccioni is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Piccioni practices. Vendor and product names are available with a free account.

Neurology is Dr. Piccioni's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Piccioni is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Piccioni has a license on file in California.

Dmand AI lists cerebrovascular disease, epilepsy and seizures among the conditions Dr. Piccioni treats.

CMS data shows 793 Medicare services from Dr. Piccioni across 3 procedure codes in 2024, for 169 Medicare patients. Medicare paid $54,893 for them.

CMS counts 169 Medicare patients who saw Dr. Piccioni in 2024. The largest group is 65 to 74, with 71 patients. 59% of them have high cholesterol, and 57% have high blood pressure. 31% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Piccioni's median patient age at 53, with 53% women.

In 2024, Dr. Piccioni wrote 435 Medicare Part D claims for 77 patients. 85% of them were for generic drugs. CMS names the drug for 294 of them, across 15 drugs with 11 or more claims each, at $636,694 in total drug cost. In 2023, CMS named 261 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Piccioni for performance year 2024, reported as part of a group. Dr. Piccioni accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Piccioni as offering telehealth.

Dmand AI links 77 papers to Dr. Piccioni, published from 2012 to 2024. 2015 was the busiest year, with 8. The most frequent topics are Brain Neoplasms, Glioblastoma and High-Throughput Nucleotide Sequencing. Dr. Piccioni has published most often in J Neurooncol. Dr. Piccioni's most frequent co-authors are Santosh Kesari, MD, PhD, Paul Timothy Fanta, MD and Gregory Aram Daniels, MD, PhD.

Dmand AI links Dr. Piccioni to 13 clinical trials, 5 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Astrocytoma, Glioblastoma and Brain Neoplasms. National Cancer Institute (NCI) sponsors the most, 7. Open Payments lists research payments to Dr. Piccioni that name 1 trial.

CMS Open Payments shows 57 general payments to Dr. Piccioni from 16 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 59% of the total. Abbvie Inc. paid the most, $2,628. It also lists 1 research payment totaling $13 in 2017, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Piccioni, most recently CMS Stage 1 EHR in 2013.

Dr. Piccioni graduated from Jacobs School of Medicine and Biomedical Sciences in 2005.

Dr. Piccioni is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.